MedTrace Logo

Effects of Abrocitinib Treatment on Skin Barrier Function

NCT05140239 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-12-04

No results posted yet for this study

Summary

Effects of abrocitinib treatment of atopic dermatitis on skin barrier function.

Conditions

Interventions

OTHER

No Intervention

Non Interventional

Sponsors & Collaborators

  • Prof. Dr. Stephan Weidinger

    lead OTHER

Principal Investigators

  • Stephan Weidinger, MD · UKSH Kiel, University of Kiel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2024-09-30
Completion
2025-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05140239 on ClinicalTrials.gov